Cory David A

Avg. Two Year Performance

(23%) Avg. Purchase Return
(11%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(21%)(29%)(46%)(23%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

President and CEO, Director:

Holdings: 169.18K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--